Search Results 121-130 of 17248 for Bacteremia

  1. TMJ disorders - Doctors and departments - Mayo Clinic

    ... Bacteremia, Multidrug-resistant organism infection. Show more areas of focus for Adi S. Shah, M.B.B.S.. Amit A. Shah, M.D.. Internist ...

  2. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    This is a Phase III, multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of atezolizumab versus placebo in ...

  3. Infectious Diseases - Clinical trials

    The purposes of this study are to determine if patients treated with fluoroquinolone (FQ) antibiotics have depletion of mitochondrial DNA (mtDNA) in buccal ...

  4. Azithromycin (oral route) - Side effects & dosage - Mayo Clinic

    Liver disease with prior azithromycin use, history of—Should not be used in patients with this condition. Bacteremia (blood infection) or; Cystic fibrosis or ...

  5. HIV/AIDS - Doctors and departments - Mayo Clinic

    ciated infection , Bacteremia. Show more areas of focus for Mac Chesdachai, M.D.. Hind J. Fadel, M.D., Ph.D. Rochester, MN. Areas of ...

  6. Coronavirus disease 2019 (COVID-19) - Doctors and departments - Mayo Clinic

    ... Bacteremia, Multidrug-resistant organism infection. Show more areas of focus for Adi S. Shah, M.B.B.S.. Bright P. Thilagar, M.D..

  7. physical exam Archives - Mayo Clinic News Network

  8. Understanding and preventing antimicrobial resistance - Mayo Clinic News Network

    18–24, serves as a global call to action to address antimicrobial resistance (AMR) — a growing public health concern that occurs when bacteria, viruses, fungi ...

  9. Tiny blood vessels, called capillaries, link the smallest parts of your arteries to the smallest parts of your veins. Petechiae form when capillaries bleed, ...

  10. Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of BL-M05D1 In Subjects With Solid Tumors - Mayo Clinic

    ... bacteremia, sepsis, etc., within 1 week prior to first dose of study treatment. Subjects on stable oral antimicrobials with no clinical or laboratory ...